The largest database of trusted experimental protocols

4 protocols using heparin sodium salt

1

Airway Epithelial Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For air-liquid interface (ALI) cultures58 (link), 100,000 cultured epithelial cells per well were added to 0.4μm pore 24-well polyester membrane inserts (Corning) pre-coated with 0.03 mg/mL Type I bovine collagen solution (StemCell Technologies) with Pneumacult-Ex media (Stemcell Technologies, 05008) on both sides of the membrane. After 24 hours, apical media was changed to remove dead cells. After 72 hours, apical media was removed completely and basal media was changed to Pneumacult-ALI (Stemcell Technologies, 05001) supplemented with 5 mL 100x penicillin-streptomycin (Fisher), 1 mL 500x gentamicin/amphotericin B (ThermoFisher), 1 mL 0.2% heparin sodium salt in PBS (Stemcell Technologies) and 2.5 mL 200x hydrocortisone stock solution (Stemcell Technologies) and 0, 0.1, 1 or 10 ng/mL IL-13 (Biolegend). Basal media was changed every 2–3 days for 21 days, after which membranes were removed and cells dissociated with Stempro Accutase Cell Dissociateion Reagent (Gibco) for Seq-Well or flow cytometry. After following scRNA-seq data analysis pipelines described above, cell states recovered in ALI cultures (Fig. 5a; Extended Data Fig. 9g) were related to in vivo cell types59 (link).
+ Open protocol
+ Expand
2

Airway Epithelial Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For air-liquid interface (ALI) cultures58 (link), 100,000 cultured epithelial cells per well were added to 0.4μm pore 24-well polyester membrane inserts (Corning) pre-coated with 0.03 mg/mL Type I bovine collagen solution (StemCell Technologies) with Pneumacult-Ex media (Stemcell Technologies, 05008) on both sides of the membrane. After 24 hours, apical media was changed to remove dead cells. After 72 hours, apical media was removed completely and basal media was changed to Pneumacult-ALI (Stemcell Technologies, 05001) supplemented with 5 mL 100x penicillin-streptomycin (Fisher), 1 mL 500x gentamicin/amphotericin B (ThermoFisher), 1 mL 0.2% heparin sodium salt in PBS (Stemcell Technologies) and 2.5 mL 200x hydrocortisone stock solution (Stemcell Technologies) and 0, 0.1, 1 or 10 ng/mL IL-13 (Biolegend). Basal media was changed every 2–3 days for 21 days, after which membranes were removed and cells dissociated with Stempro Accutase Cell Dissociateion Reagent (Gibco) for Seq-Well or flow cytometry. After following scRNA-seq data analysis pipelines described above, cell states recovered in ALI cultures (Fig. 5a; Extended Data Fig. 9g) were related to in vivo cell types59 (link).
+ Open protocol
+ Expand
3

Plasma-based Alzheimer's Indicator Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
We developed an indicator cell assay to detect AD from human plasma samples at two stages of progression: preclinical (cognitively normal patients with positive CSF AD biomarkers; N = 20) and early symptomatic (patients with mild cognitive impairment or early AD and positive CSF AD biomarkers) when compared to healthy controls (cognitively normal patients with negative CSF AD biomarkers). The study involved analysis of 18–20 samples of each class, which were processed in randomly selected batches, each containing an equal number of samples from each class. Indicator cells for this experiment were a commercially available, pan-neuronal population of glutamatergic and GABAergic neurons derived from induced pluripotent stem cells (iPSCs) (iCell Neurons from Cellular Dynamics International (CDI)). For this experiment, the neurons were thawed and plated in a 12-well dish (at 600,000 cells/well) and after culturing for 5 d, cells were exposed to 10% plasma containing 0.2 mg/mL heparin sodium salt in PBS (Stem Cell Technologies) for 24 h. RNA was isolated and used for gene expression analysis with Affymetrix human exon arrays (ST 1.0). Neurons were guaranteed free from mycoplasma contamination from CDI and were not tested again during the experiment.
+ Open protocol
+ Expand
4

Culturing Patient-Derived GBM Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient-derived GBM cell lines were cultured in NSA medium, composed of: reconstituted human NeuroCult™ NS-A Proliferation kit (Stem Cell Technologies) supplemented with 20µg/ml heparin sodium salt (Stem Cell Technologies), 20ng/ml rhEGF (Peprotech), 20ng/ml b-FGF (Peprotech) and 1% antibiotic/antimycotic (Life Technologies). Flasks or plates were coated with 5µg/ml laminin freshly prepared by diluting 1mg/ml laminin solution (Sigma Aldrich) in dPBS. The flasks/plates were then incubated at 37degrees for at least 1 hour. For seeding cells, laminin was aspirated and fresh medium added immediately. For maintenance, cells were scraped off and re-plated into laminin coated flasks. Accutase (Life Technologies) was used to dissociate neurospheres and to obtain a single cell suspension, when required. All cell lines were confirmed to be mycoplasma free, based on routine testing using the MycoAlert Mycoplasma Detection Kit (Lonza).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!